Cancer drugs may remain approved despite lack of benefit
Reuters Health, Andrew M. Seaman
Dec 5, 2016
1 min read
In the United States, cancer drugs are sometimes approved through sped-up processes - and they often stay approved even if later studies show them to be inferior to other options or even worse than doing nothing, a new study found.
Comments